Tailored modulation of S100A1 and RASSF8 expression by butanediamide augments healing of rotator cuff tears.
PeerJ（2023）
摘要
S100A1 and RASSF8 are pivotal genes implicated in RCTs, and their roles have been elucidated. The FDA-approved compound, Butanediamide, may represent a prospective therapeutic agent for RCTs by targeting S100A1 and RASSF8, respectively.
更多查看译文
关键词
rotator cuff,butanediamide augments healing,s100a1,rassf8 expression
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要